The Injection-Related InfectionS (IRIS) Program

Launched by MCMASTER UNIVERSITY · Dec 5, 2023

Keywords

ClinConnect Summary

The Injection-Related InfectionS (IRIS) program is a clinical trial designed to help people who inject drugs and are at risk of infections related to their injections, such as skin infections or heart infections. The goal of this program is to provide easier access to comprehensive care that addresses both their health and substance use needs in a supportive environment. Participants will receive care for their infections along with peer support, which means they’ll have the chance to connect with others who understand their experiences. The trial aims to enroll 80 participants who will be monitored for about 6 to 12 weeks during their treatment.

To be eligible for the IRIS program, participants need to be 16 years or older, living in Hamilton, Ontario, and have a confirmed or suspected injection-related infection. They should also have a history of injection drug use within the last three months. Throughout the trial, the team will collect information on participants' health, including how well they complete their treatment and whether they need to visit the emergency room or be hospitalized. This study will help researchers understand how this new model of care can improve health outcomes for individuals facing these challenges.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age 16 or older
• • Able to provide informed consent
• • Presenting with a confirmed or suspected injection-related infection (including skin and soft tissue infections, osteomyelitis, infective endocarditis, Hepatitis C, HIV, etc)
• • History of injection drug use within 3 months of recruitment
• • Lives in Hamilton, Ontario
• Exclusion Criteria:
• • -